Trade BioNTech ^BNTX

HC Wainwright Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)

BNTX Reiterates by HC Wainwright & Co. -- Price Target Maintaine

CureVac sues Moderna for patent infringement over COVID-19 vaccines

BioNTech SE (BNTX) PT Slightly Raised as Morgan Stanley Updates Biopharma Coverage Models

Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock

Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer

BioNTech (BNTX) Price Target Raised Following Successful T-Pam Data

BioNTech (NASDAQ:BNTX) COO Sierk Poetting Sells 50,000 Shares - Daily Political

BioNTech (BNTX) Is Up 13.4% After Positive HER2 Endometrial Cancer Phase 2 Data Release

BNTX: Leadership Turnover And Weak COVID Outlook Will Pressure Future Expectations

BioNTech (BNTX) Gains Investor Interest Following Promising ASCO Presentation

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Recent Share Price Momentum

BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story

Lbp Am Sa Acquires 15,255 Shares of BioNTech SE Sponsored ADR $BNTX

BioNTech's (BNTX) Buy Rating Reiterated at Berenberg Bank - Daily Political

BioNTech (BNTX) Is Up 9.8% After Strong Phase 2 HER2 ADC Data - Has The Bull Case Changed?

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $133.13 - Stock Observer

BioNTech (NASDAQ:BNTX) Earns "Buy" Rating from Berenberg Bank - Stock Observer

A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data

BioNTech announce Phase 2 cohort of BNT323 met primary efficacy endpoint | Markets Insider

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer | Taiwan News | Apr. 11, 2026 19:00

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Recommendation of "Moderate Buy" by Analysts

BioNTech (NASDAQ:BNTX) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Aberdeen Group plc Lowers Stock Position in BioNTech SE Sponsored ADR $BNTX

How The BioNTech (BNTX) Story Is Shifting With New Leadership And Post COVID Pipeline Bets

Is BioNTech (BNTX) Quietly Rewriting Its Investment Story Around Oncology Beyond COVID Vaccines?

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Analyst Moves And COVID Vaccine Trial Setback

HC Wainwright Issues Negative Estimate for BioNTech Earnings

BioNTech to close vaccine manufacturing plant in Singapore in by 2027 - CNA

Pfizer (NYSE:PFE) Stock Price Up 1.7% - Still a Buy? - Markets Daily

Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 - Here's Why

BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at HC Wainwright

3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Sees Significant Decrease in Short Interest - Daily Political

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Short Interest Down 20.7% in March